BioMarin Pharmaceutical has agreed to acquire Inozyme Pharma for $4.00 per share in a $270m all-cash transaction. This will ...

It’s essential for bone health. Vitamin D supports healthy bone formation and bone remodeling, says Araujo. It helps slow ...

Vitamin D deficiency is the state of having inadequate amounts of vitamin D in your body, which may cause health-related ...

BioMarin Pharmaceutical Inc. and Inozyme Pharma, Inc. announced that BioMarin has entered into a definitive agreement to acquire Inozyme for $4.00 per share in an all-cash transaction for a total ...

WHETHER it’s stiffness when sitting up from a chair or painful twinges when tackling the stairs, knee problems are a common health issue, affecting people of all ages. One knee-related ...

BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately $270M.

Acquisition is Strong Strategic Fit for BioMarin, Adding INZ-701, a Phase 3 Enzyme Replacement Therapy Being Developed for Treatment of ENPP1 DeficiencyFirst Pivotal Data Readout in Children ...

A lack of calcium could lead to a condition called rickets in children, and osteomalacia or osteoporosis in later life." Calcium is essential for muscle movement and for transmitting messages ...

A lack of calcium could lead to a condition called rickets in children, and osteomalacia or osteoporosis in later life." Calcium is essential for muscle movement and for transmitting messages ...

Medically reviewed by Femi Aremu, PharmD Vitamin D3 (cholecalciferol) is a form of vitamin D naturally found in some foods ...

Detailed price information for Inozyme Pharma Inc (INZY-Q) from The Globe and Mail including charting and trades.

X-linked hypophosphatemia (XLH), autosomal dominant hypophosphatemic rickets and tumor-associated osteomalacia. Hypophosphatemia had previously been linked to rhabdomyolysis, hemolysis ...